Concepedia

Indranil Banerjee

IB

Statistics

Publications

21

Citations

781

H-Index

16

Active since

2012

Affiliations

Indian Institute of Technology Kharagpur(Current)

Indian Institute of Chemical Biology

Virginia Commonwealth University

Jadavpur University

Council of Scientific and Industrial Research

Indranil Banerjee is an author at Indian Institute of Technology Kharagpur specializing in oncology, medicine, and pharmacology.

Publications per year

2012–2022

21

Publications

21

Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy

Indranil Banerjee, Kakali De, Dibyanti Mukherjee et al. · Acta Biomaterialia · 2016 · 96 citations

Pharmacy, Oncology, Pharmacology +14

Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy

Rashmi Bharti, Goutam Dey, Indranil Banerjee et al. · Cancer Letters · 2016 · 82 citations

Medicine, Oncology, Pharmacology +14

A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes

Manjarika De, Sneha Ghosh, Triparna Sen et al. · Molecular Therapy — Nucleic Acids · 2017 · 58 citations · Full text

Pharmacy, Oncology, Pharmacology +17

TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation

Bikash Chandra Jena, Chandan Kanta Das, Indranil Banerjee et al. · Experimental Cell Research · 2022 · 57 citations

Life Sciences, Cell Biology, Oncology +14

Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma

Y. Rajesh, Angana Biswas, Utkarsh Kumar et al. · Biochemical Pharmacology · 2019 · 55 citations

Medicine, Oncology, Pharmacology +16

1–5 of 21